TY - JOUR
T1 - Spatial Mapping of Myeloid Cells and Macrophages by Multiplexed Tissue Staining
AU - Saylor, Joshua
AU - Ma, Zhaoxuan
AU - Goodridge, Helen S.
AU - Huang, Fangjin
AU - Cress, Anne E.
AU - Pandol, Stephen J.
AU - Shiao, Stephen L.
AU - Vidal, Adriana C.
AU - Wu, Lily
AU - Nickols, Nicholas G.
AU - Gertych, Arkadiusz
AU - Knudsen, Beatrice S.
N1 - Publisher Copyright:
© Copyright © 2018 Saylor, Ma, Goodridge, Huang, Cress, Pandol, Shiao, Vidal, Wu, Nickols, Gertych and Knudsen.
PY - 2018/12/14
Y1 - 2018/12/14
N2 - An array of phenotypically diverse myeloid cells and macrophages (MC&M) resides in the tumor microenvironment, requiring multiplexed detection systems for visualization. Here we report an automated, multiplexed staining approach, named PLEXODY, that consists of five MC&M-related fluorescently-tagged antibodies (anti - CD68, - CD163, - CD206, - CD11b, and - CD11c), and three chromogenic antibodies, reactive with high- and low-molecular weight cytokeratins and CD3, highlighting tumor regions, benign glands and T cells. The staining prototype and image analysis methods which include a pixel/area-based quantification were developed using tissues from inflamed colon and tonsil and revealed a unique tissue-specific composition of 14 MC&M-associated pixel classes. As a proof-of-principle, PLEXODY was applied to three cases of pancreatic, prostate and renal cancers. Across digital images from these cancer types we observed 10 MC&M-associated pixel classes at frequencies greater than 3%. Cases revealed higher frequencies of single positive compared to multi-color pixels and a high abundance of CD68+/CD163+ and CD68+/CD163+/CD206+ pixels. Significantly more CD68+ and CD163+ vs. CD11b+ and CD11c+ pixels were in direct contact with tumor cells and T cells. While the greatest percentage (~70%) of CD68+ and CD163+ pixels was 0–20 microns away from tumor and T cell borders, CD11b+ and CD11c+ pixels were detected up to 240 microns away from tumor/T cell masks. Together, these data demonstrate significant differences in densities and spatial organization of MC&M-associated pixel classes, but surprising similarities between the three cancer types.
AB - An array of phenotypically diverse myeloid cells and macrophages (MC&M) resides in the tumor microenvironment, requiring multiplexed detection systems for visualization. Here we report an automated, multiplexed staining approach, named PLEXODY, that consists of five MC&M-related fluorescently-tagged antibodies (anti - CD68, - CD163, - CD206, - CD11b, and - CD11c), and three chromogenic antibodies, reactive with high- and low-molecular weight cytokeratins and CD3, highlighting tumor regions, benign glands and T cells. The staining prototype and image analysis methods which include a pixel/area-based quantification were developed using tissues from inflamed colon and tonsil and revealed a unique tissue-specific composition of 14 MC&M-associated pixel classes. As a proof-of-principle, PLEXODY was applied to three cases of pancreatic, prostate and renal cancers. Across digital images from these cancer types we observed 10 MC&M-associated pixel classes at frequencies greater than 3%. Cases revealed higher frequencies of single positive compared to multi-color pixels and a high abundance of CD68+/CD163+ and CD68+/CD163+/CD206+ pixels. Significantly more CD68+ and CD163+ vs. CD11b+ and CD11c+ pixels were in direct contact with tumor cells and T cells. While the greatest percentage (~70%) of CD68+ and CD163+ pixels was 0–20 microns away from tumor and T cell borders, CD11b+ and CD11c+ pixels were detected up to 240 microns away from tumor/T cell masks. Together, these data demonstrate significant differences in densities and spatial organization of MC&M-associated pixel classes, but surprising similarities between the three cancer types.
KW - FFPE
KW - immunofluorescence
KW - immunohistochemistry
KW - macrophage
KW - multiplex
KW - myeloid
KW - spatial profiling
UR - http://www.scopus.com/inward/record.url?scp=85059929261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059929261&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2018.02925
DO - 10.3389/fimmu.2018.02925
M3 - Article
C2 - 30619287
AN - SCOPUS:85059929261
SN - 1664-3224
VL - 9
JO - Frontiers in immunology
JF - Frontiers in immunology
M1 - 2925
ER -